( August 25, 2026, 2:55 PM EDT) -- BOSTON — A Massachusetts federal magistrate judge on Aug. 24 granted in part nonparty pharmaceutical manufacturers’ motions to quash subpoenas in a suit against Regeneron Pharmaceuticals Inc. alleging violations of the federal False Claims Act (FCA) and similar state laws for purportedly fraudulent sales price reporting for a vision impairment drug, finding that the evidence sought could be relevant to scienter....